Featured Research

from universities, journals, and other organizations

New tick disease in Switzerland

Date:
October 31, 2012
Source:
University of Zurich
Summary:
Until now, it has been known that ticks primarily transmit two pathogens to humans in Switzerland: the bacterium Borrelia burgdorferi -- which causes borreliosis -- and the early-summer-meningoencephalitis virus, which can cause cerebral inflammation. Now, microbiologists confirm the existence of another tick disease in Switzerland -- neoehrlichiosis.

Until now, it has been known that ticks primarily transmit two pathogens to humans in Switzerland: the bacterium Borrelia burgdorferi -- which causes borreliosis -- and the early-summer-meningoencephalitis virus, which can cause cerebral inflammation. Now, microbiologists from the University of Zurich confirm the existence of another tick disease in Switzerland -- neoehrlichiosis.

The pathogenic bacteria Candidatus Neoehrlichia mikurensis was first discovered in ticks and rodents in Europe and Asia in 1999. In 2010, Head of Molecular Diagnostics at the Institute of Medical Microbiology Guido Bloemberg and colleagues from Sweden and Germany diagnosed the world's first infections in humans and dubbed the disease "neoehrlichiosis," by detection of the bacterium in the patients blood. Two more cases were identified at the University of Zurich's Institute of Medical Microbiology in November 2011 and December 2012. So far, a total of eight patients have been described in Europe, three of whom come from the Zurich area. They suffered from relapsing fevers of up to 40 degrees, weight loss and general malaise.

Greater Zurich region risk area

Bloemberg's team studied around 2,000 ticks from the neighborhood of the three Swiss patients, who often spent time in forests and fields. The result: A large number of ticks in the Zurich area -- five to ten percent -- carry Candidatus Neoehrlichia mikurensis. "Our study shows that the greater Zurich region is a risk area for neoehrlichiosis, especially for immunocompromised people," explains Florian Maurer from the University of Zurich's Institute of Medical Microbiology. Almost all the patients in Europe to date have had a weakened immune system. However, people with a healthy immune system recently contracted neoehrlichiosis from a tick bite in China, too.

New test detects infection quickly

"Because the bacteria that cause neoehrlichiosis couldn't be bred in the lab until now and thus no rapid tests were available, many infections might have remained undetected," says Guido Bloemberg. However, help is now at hand with the new DNA test the researchers have developed: It can detect an infection definitively within one working day and also be used for larger test series.

The Swiss patients could be cured fully with a course of antibiotics. Within only a few weeks of beginning the treatment, the microorganism responsible could no longer be detected in their blood. "How well the bacterium is transmitted to humans via a bite from an infected tick, however, still needs to be researched," concludes Bloemberg.


Story Source:

The above story is based on materials provided by University of Zurich. Note: Materials may be edited for content and length.


Journal Reference:

  1. F. P. Maurer, P. M. Keller, C. Beuret, C. Joha, Y. Achermann, J. Gubler, D. Bircher, U. Karrer, J. Fehr, L. Zimmerli, G. V. Bloemberg. Close geographic association of human neoehrlichiosis and tick populations carrying Candidatus Neoehrlichia mikurensis in Eastern Switzerland.. Journal of Clinical Microbiology, 2012; DOI: 10.1128/JCM.01955-12

Cite This Page:

University of Zurich. "New tick disease in Switzerland." ScienceDaily. ScienceDaily, 31 October 2012. <www.sciencedaily.com/releases/2012/10/121031081516.htm>.
University of Zurich. (2012, October 31). New tick disease in Switzerland. ScienceDaily. Retrieved September 22, 2014 from www.sciencedaily.com/releases/2012/10/121031081516.htm
University of Zurich. "New tick disease in Switzerland." ScienceDaily. www.sciencedaily.com/releases/2012/10/121031081516.htm (accessed September 22, 2014).

Share This



More Health & Medicine News

Monday, September 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins